Risk-adapted treatment of acute promyelocytic leukemia with AIDA derived regimens: The Pethema experience

被引：0
作者：
Sanz, M. A. [1 ]
机构：
[1] Hosp Univ La Fe, Hematol Serv, Valencia, Spain
来源：
ANNALS OF HEMATOLOGY | 2006年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：98 / 99
页数：2
相关论文
共 8 条
[1]  
Ades L, 2004, BLOOD, V104, p115A
[2]  
Lo-Coco F, 2004, BLOOD, V104, P392
[3]  
Sanz MA, 2000, BLOOD, V96, P1247
[4]   All-trans retinoic acid and anthracycline monochemotherapy for the treatment of elderly patients with acute promyelocytic leukemia [J].
Sanz, MA ;
Vellenga, E ;
Rayón, C ;
Díaz-Mediavilla, J ;
Rivas, C ;
Amutio, E ;
Arias, J ;
Debén, G ;
Novo, A ;
Bergua, J ;
de la Serna, J ;
Bueno, J ;
Negri, S ;
de Heredia, JM ;
Martín, G .
BLOOD, 2004, 104 (12) :3490-3493
[5]  
Sanz MA, 2005, J CLIN ONCOL, V23, p563S
[6]   Choice of chemotherapy in induction, consolidation and maintenance in acute promyelocytic leukaemia [J].
Sanz, MA ;
Martín, G ;
Lo Coco, F .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2003, 16 (03) :433-451
[7]  
Sanz MA, 2005, HAEMATOLOGICA, V90, P1231
[8]   Acute promyelocytic leukemia: evolving therapeutic strategies [J].
Tallman, MS ;
Nabhan, C ;
Feusner, JH ;
Rowe, JM .
BLOOD, 2002, 99 (03) :759-767
1